Search for more clinical trials
Specimen Banking From Patients With Lung Cancer
Conditions
Lung Neoplasms
Conditions: official terms
Lung Neoplasms
Conditions: Keywords
Lung Cancer
Study Type
Observational
Study Phase
N/A
Study Design
Time Perspective: Prospective
Overall Status
Recruiting
Summary
The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.
Detailed Description
The aims of the study are as follows: 1) to continue to unravel the complex biology of lung cancer 2) to identify early detection and prognostic markers to guide therapeutic decision 3) to define markers of response and/or resistance to drug therapy, and 4) to identify new therapeutic and prevention targets.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 85 Years
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:
1. Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer.
2. Oral and written informed consent
Exclusion Criteria:
1. Any individual who does not give oral and written consent for participation
1. Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer.
2. Oral and written informed consent
Exclusion Criteria:
1. Any individual who does not give oral and written consent for participation
Location
University of Colorado Cancer Center
Aurora, Colorado, United States
Status: Recruiting
Contact: Mary K. Jackson - 303-724-1650 - mary.k.jackson@ucdenver.edu
Start Date
November 2005
Completion Date
May 2020
Sponsors
University of Colorado, Denver
Source
University of Colorado, Denver
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page